Monocytes, macrophages and polymorphonuclear neutrophils (PMN) are critical to initiation of the immune response and to the effector phase of immune defense, and are involved in a variety of pathologic disorders. Fc receptors for IgG (FcgammaR) are important mediators of many activities of these cells. During the past four years, we have examined in some detail the properties of FcgammaR and their role in the functional activity of the cells on which they are expressed. In this renewal application, we propose studies to develop a better understanding of the additional molecular interrelationships that influence the activity of each of the classes of FcgammaR on monocytes, macrophages and polymorphonuclear neutrophils. In particular, 1) we propose to extend our studies of the signaling and functional properties of the FcgammaR on human myeloid cells to determine the effects of joint ligation of the different FcgammaR or their isoforms. These studies would involve the use of combinations of bispecific antibodies targeting to different FcgammaR types as well as quadroma self directed targets expressing two different anti-FcgammaR antibodies. 2) We would determine the role of cognate interactions in monocytes/macrophages activation and FcgammaR functional properties. Although it is clear that monocytes/macrophages require both cytokine and cognate interactions for appropriate function against some targets, the importance of these interactions in myeloid cell function has not been comprehensively explored. We would examine the role of CD40, TNFR, LFA- 3 and LFA-1 in signaling monocytes and macrophages activation and in several critical functions, including: phagocytosis, ADCC, superoxide generation, cytokine release and antigen presentation. 3) Finally, we would determine the role of myeloid cells and their receptors (FcgammaR and accessory molecules) in toxoplasma infection and killing, as a physiologically relevant model of FcgammaR function. These studies should result in a far clearer understanding of the functional abilities of the different FcgammaR on human myeloid cells and the influence of other physiologically relevant molecular interrelationships on the activity of each of the classes of FcgammaR. Since myeloid cell populations and FcgammaR are central to a number of critical functions, information obtained in the proposed studies will be useful in designing strategies for modulating the activity of these molecules and the critical cell populations with which they are associated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI019053-14
Application #
2060859
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1981-09-01
Project End
1999-03-31
Budget Start
1995-04-01
Budget End
1996-03-31
Support Year
14
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Guyre, C A; Keler, T; Swink, S L et al. (2001) Receptor modulation by Fc gamma RI-specific fusion proteins is dependent on receptor number and modified by IgG. J Immunol 167:6303-11
Wallace, P K; Tsang, K Y; Goldstein, J et al. (2001) Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I. J Immunol Methods 248:183-94
Guyre, C A; Barreda, M E; Swink, S L et al. (2001) Colocalization of Fc gamma RI-targeted antigen with class I MHC: implications for antigen processing. J Immunol 166:2469-78
Wallace, P K; Romet-Lemonne, J L; Chokri, M et al. (2000) Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcgammaRI and the epidermal growth factor receptor. Cancer Immunol Immunother 49:493-503
Wallace, P K; Keler, T; Guyre, P M et al. (1997) Fc gamma RI blockade and modulation for immunotherapy. Cancer Immunol Immunother 45:137-41
Wallace, P K; Keler, T; Coleman, K et al. (1997) Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcgammaRI), blocks phagocytosis, and modulates receptor expression. J Leukoc Biol 62:469-79
Benoit, N E; Wade, W F (1996) Increased inhibition of proliferation of human B cell lymphomas following ligation of CD40, and either CD19, CD20, CD95 or surface immunoglobulin. Immunopharmacology 35:129-39
Ely, P; Wallace, P K; Givan, A L et al. (1996) Bispecific-armed, interferon gamma-primed macrophage-mediated phagocytosis of malignant non-Hodgkin's lymphoma. Blood 87:3813-21
Valone, F H; Kaufman, P A; Guyre, P M et al. (1995) Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu. J Clin Oncol 13:2281-92
Wallace, P K; Howell, A L; Fanger, M W (1994) Role of Fc gamma receptors in cancer and infectious disease. J Leukoc Biol 55:816-26

Showing the most recent 10 out of 45 publications